Last reviewed · How we verify

NCT07524153

Diode Laser and S100A8 in Peri-Implantitis

Completed Last updated 13 April 2026
What this trial tests

trial in Periimplant Diseases in 39 participants. Completed in 10 October 2025.

Timeline
1 January 2025
Primary endpoint
1 June 2025
10 October 2025

Quick facts

Lead sponsorKırıkkale University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment39
Start date1 January 2025
Primary completion1 June 2025
Estimated completion10 October 2025
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Kırıkkale University

Who can join

Adults 30 to 65, any sex, with Periimplant Diseases or S100A8. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Purpose: The aim of this study was to compare the effectiveness of diode laser and combined treatment protocols, applied in addition to mechanical debridement, in the treatment of peri-implantitis on clinical periodontal parameters and S100A8 levels in peri-implant sulcus fluid (PISF). Methods: A total of 39 patients diagnosed with peri-implantitis were divided into three groups based on the treatment protocols used: Mechanical Debridement, Diode Laser, and Combined Treatment. Probing depth, clinical attachment level, modified plaque index, gingival index, and PISF volume measurements were recorded at baseline and at weeks 4 and 12. S100A8 levels in PISF samples were measured by ELISA.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Periimplant Diseases

Currently open trials in the same condition.

Other Kırıkkale University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07524153.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing